4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Personalized Cardiology and Precision Medicine
Personalized cardiology and precision medicine are revolutionizing heart disease treatment by tailoring care to each individual based on their unique genetic makeup, lifestyle, and environment. This approach allows cardiologists to select the most effective therapies for patients, increasing the likelihood of successful outcomes and minimizing adverse effects. By utilizing advanced diagnostic tools, such as genetic testing and imaging, personalized cardiology helps identify risk factors early, enabling timely interventions. In the realm of precision medicine, therapies are designed to target specific pathways involved in the patient’s condition, ensuring more efficient treatment and improving the overall prognosis for heart disease patients.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Samir Rafla
Alexandria University, Egypt
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, ArgentinaSubmit your abstract Today
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile